0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product Type (Software and Device), and Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)): Global Opportunity Analysis and Industry Forecast, 2020–2027
Published Date: November 2021
|
Report Code: ALLI-Auto-4F289
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
 Digital Therapeutics Market by Application Diabetes Obesity Cardiovascular Diseases CVD Central Nervous System CNS Disease Gastrointestinal Disorders GID Respiratory Diseases Smoking Cessation and Others Product Software and Devices and Sales Channel Business to business B2B and Business to consumers B2C Global Opportunity Analysis and Industry Forecast 2017 2025

Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product Type (Software and Device), and Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)): Global Opportunity Analysis and Industry Forecast, 2020–2027

Code: ALLI-Auto-4F289
Report
November 2021
280 Pages
Allied Market Research
Region: Global,
Description
Table of Content
Tables & Figures

Digital Therapeutics Market Statistics 2027

The global digital therapeutics market size was valued at USD 2.88 Billion in 2019 and is expected to reach USD 13.80 Billion by 2027 with a CAGR of 20.5% during the forecast period. The increasing adoption of mobile and tablet devices, the expansion of healthcare apps, the growing need to track healthcare expenses, and the rising incidence of chronic diseases are all driving the worldwide digital therapeutics market. Furthermore, the digital therapeutics industry's producers could profit handsomely from significant growth possibilities in undeveloped areas. 

Digital therapeutics market

What is Digital Therapeutics Market 

Digital therapeutics is a subset of digital health that offers patients evidence-based therapy options that are supported by high-quality software. The difference between digital health and digital therapeutics is based on the clinical outcomes of the patients. 

Trends Influencing the Growth of Digital Therapeutics Market 

The widespread availability of smartphones has resulted in a significant shift in how individuals use their devices to access healthcare, making it a perfect platform for delivering cutting-edge digital therapy. During the forecast period, the market size for digital therapeutics is predicted to grow due to the increasing penetration of digital devices such as smartphones and tablets. 

digital therapeutics market size

 

The expansion of the digital therapeutics market has been fueled by rising healthcare costs. Due to escalating drug and service prices, healthcare costs have risen to unsustainable levels in recent years. As a result, large corporations and the government-run healthcare system have begun to employ new treatments.

In order to scale up to a large number of patients and enhance healthcare results, digital therapies are increasingly being used. Digital treatment has proven its worth in the management of diabetes and other chronic diseases. As a result, the market for digital therapeutics is likely to grow as the prevalence of chronic disease rises. 

The expansion of the digital therapeutics market is hampered by a lack of awareness about digital therapeutics in developing countries, as well as concerns about patient data protection.

Application Segment Review

On the basis of application, the digital therapeutics market is segmented into diabetes, obesity, cardiovascular disease, central nervous system disease, respiratory disease, smoking cessation, gastrointestinal disorder, and others. The diabetes segment was the major revenue contributor in 2019, and is anticipated to continue this trend during the forecast period, owing to high prevalence of diabetes. In addition, demand for cost-effective healthcare options and highest comparative prevalence rates for diabetes are observed in North America, the Middle East, and North Africa, which further boosts the demand for digital therapeutics among diabetic patients in these regions. However, the obesity segment is projected to exhibit the highest growth during the forecast period.

This is attributed to increase in number of overweight populations, which increases the number of chronic diseases, owing to obesity. In addition, better accessibility of digital therapeutics software application help patients to maintain their proper diet as well as track health data and daily physical activities. Moreover, the software application provides regular online assistance from certified doctors, which is expected to help in reducing prevalence of obesity in the future. Furthermore, several companies have launched a variety of digital therapeutics products. For instance, in 2017, Oxil launched an app to tackle increasing cases of obesity among youth. Moreover, Azumio provides fitness buddy mobile app that offers largest exercise database, which helps reduce obesity. The analysis done by Noom Inc. demonstrated that 78% of users lost weight with its mobile health coaching solutions.

Digital therapeutics market by product type

Product Segment Review

Depending on product, the digital therapeutics market is categorized into software and devices. The software segment is projected to exhibit the highest growth during the forecast period. This is attributed to rise in demand for reducing healthcare costs across the world. This gives immense opportunities to developers to use existing software and develop new and advanced features to make them more effective and affordable. Thus, is anticipated to help in increasing the digital therapeutics market size in the future.

Region Segment Review

Region wise, the digital therapeutics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2019, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to increase in geriatric population, rise in incidences of chronic diseases, surge in demand for wireless & portable systems, and availability of sophisticated reimbursement structure that aims in reducing expenditure.

Digital Therapeutics Market Segmentation

By Application

  • Diabetes
  • Obesity
  • Cardiovascular Disease (CVD)
  • Central Nervous System (CNS) Disease
  • Respiratory Disease
  • Smoking Cessation
  • Gastrointestinal Disorder (GID)
  • Others

By Product Type 

  • Software
  • Device

By Sales Channel

  • Business-to-Business (B2B)
    • Employer
    • Healthcare Provider
    • Others
  • Business-to-Consumer (B2C)
    • Patient
    • Caregiver

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Japan
    • India
    • China
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • Turkey
    • Saudi Arabia 
    • South Africa
    • Rest of LAMEA

Key Companies

  • 2MORROW, Inc.,
  • Akili Interactive Labs, Inc.,
  • Click Therapeutics, Inc.,
  • Fitbit, Inc. (Twine Health, Inc.),
  • Happify, Inc.,
  • Kaia Health,
  • Livongo Health, Inc.,
  • Medtronic Plc.,
  • Omada Health, Inc.,
  • Pear Therapeutics, Inc.,
  • Proteus Digital Health, Inc.,
  • Resmed, Inc. (Propeller Health),
  • Voluntis, Inc.,
  • Welldoc, Inc.
  • Canary Health Inc.,
  • Mango Health Inc.,
  • Noom, Inc.,
  • Dthera Sciences.

Report Metric

Details

Report Name

Digital Therapeutics Market

Market size value in 2019

USD 2.88 Billion

Revenue forecast in 2027

USD 13.80 Billion

CAGR

20.5%

  By Product Type

Software, Device

  By Application

Diabetes, Obesity, Cardiovascular disease, Central nervous system disease, Respiratory disease, Smoking cessation, Gastrointestinal disorder

By Sales Channel

B2B, B2C

Frequently Asked Questions About This Report

1. How big is the Digital therapeutics market?

Ans: The global digital therapeutics market size is expected to reach USD 13.80 Billion by 2027 with a CAGR of 20.5%.

2. Which is the most lucrative segment in the Digital therapeutics market?

Ans: Software segment is projected as one of the most lucrative segments.

3. Who are the key companies the Digital therapeutics market?

Ans: Some of the major companies are 2MORROW, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., Fitbit, Inc. (Twine Health, Inc.), Happify, Inc., Kaia Health, Livongo Health, Inc., Medtronic Plc., Omada Health, Inc., Pear Therapeutics, Inc., Proteus Digital Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Welldoc, Inc.

4. Which region would exhibit the highest levels of growth in Digital therapeutics market?

Ans: Asia-Pacific region would exhibit the highest CAGR of 22.2% during 2020-2027.

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key Market Segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Top player positioning, 2019
3.4.Porter’s five forces analysis
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in adoption of smartphones and tablets, coupled with healthcare apps
3.5.1.2.Growth in need to control healthcare costs
3.5.1.3.Rise in incidences of chronic diseases

3.5.2.Restraints

3.5.2.1.Lack of awareness regarding digital therapeutics in developing countries
3.5.2.2.Patient data privacy concerns

3.5.3.Opportunity

3.5.3.1.Emerging markets offer significant growth opportunities

3.6.Impact analysis of COVID-19 on the digital therapeutics market
3.7.Impact of government regulations on global digital therapeutics market

3.7.1.U.S. FDA’s premarket clearance and approval requirements
3.7.2.European Union premarket clearance and approval requirements
3.7.3.Japan premarket clearance and approval requirements

3.8.Strategy adopted by top 10 start-ups

3.8.1.Meru Health, Inc.
3.8.2.Bold Health Limited
3.8.3.BehaVR, LLC
3.8.4.Naluri Hidup Sdn Bhd
3.8.5.Big Health
3.8.6.Hinge Health, Inc.
3.8.7.Glooko, Inc.
3.8.8.Holmusk Pte. Ltd.
3.8.9.Wellthy Therapeutics Pvt Ltd.
3.8.10.Virta Health Corp.

3.9.Key digital technologies for digital therapeutics

3.9.1.Mobile health (mHealth)
3.9.2.Personalized healthcare
3.9.3.Digital Cognitive Behavior Therapy (CBT)
3.9.4.Wearable devices and sensors

3.10.Necessary human resources required for digital therapeutics development
3.11.Usage of patient data acquired from digital therapeutics

3.11.1.Types of personal information that are collected by DTx companies

CHAPTER 4:DIGITAL THERAPEUTICS MARKET, BY APPLICATION

4.1.Overview

4.1.1.Market size and forecast

4.2.Diabetes

4.2.1.Key market trends and growth opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Obesity

4.3.1.Key market trends and growth opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Cardiovascular diseases

4.4.1.Key market trends and growth opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

4.5.Central nervous system (CNS) diseases

4.5.1.Key market trends and growth opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country

4.6.Gastrointestinal disorder

4.6.1.Key market trends and growth opportunities
4.6.2.Market size and forecast
4.6.3.Market analysis, by country

4.7.Respiratory diseases

4.7.1.Key market trends and growth opportunities
4.7.2.Market size and forecast
4.7.3.Market analysis, by country

4.8.Smoking cessation

4.8.1.Key market trends and growth opportunities
4.8.2.Market size and forecast
4.8.3.Market analysis, by country

4.9.Others

4.9.1.Key market trends and growth opportunities
4.9.2.Market size and forecast
4.9.3.Market analysis, by country

CHAPTER 5:DIGITAL THERAPEUTICS MARKET, BY PRODUCT

5.1.Overview

5.1.1.Market size and forecast

5.2.Software

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Devices

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

CHAPTER 6:DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL

6.1.Overview

6.1.1.Market size and forecast

6.2.Business-to-business (B2B)

6.2.1.Market size and forecast, by type

6.2.1.1.Employer

6.2.1.1.1.Market size and forecast

6.2.1.2.Healthcare Providers

6.2.1.2.1.Market size and forecast

6.2.1.3.Others

6.2.1.3.1.Market size and forecast

6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Business-to-consumers

6.3.1.Market size and forecast, by type

6.3.1.1.Patients

6.3.1.1.1.Market size and forecast

6.3.1.2.Caregivers

6.3.1.2.1.Market size and forecast

6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

CHAPTER 7:DIGITAL THERAPEUTICS MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America digital therapeutics market, by country

7.2.2.1.U.S. digital therapeutics market, by application
7.2.2.2.U.S digital therapeutics market, by product type
7.2.2.3.U.S. digital therapeutics market, by sales channel
7.2.2.4.Canada digital therapeutics market, by application
7.2.2.5.Canada digital therapeutics market, by product type
7.2.2.6.Canada digital therapeutics market, by sales channel
7.2.2.7.Mexico digital therapeutics market, by application
7.2.2.8.Mexico digital therapeutics market, by product type
7.2.2.9.Mexico digital therapeutics market, by sales channel

7.2.3.North America digital therapeutics market, by application
7.2.4.North America digital therapeutics market, by product type
7.2.5.North America digital therapeutics market, by sales channel

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe digital therapeutics market, by country

7.3.2.1.UK digital therapeutics market, by application
7.3.2.2.UK digital therapeutics market, by product type
7.3.2.3.UK digital therapeutics market, by sales channel
7.3.2.4.Germany digital therapeutics market, by application
7.3.2.5.Germany digital therapeutics market, by product type
7.3.2.6.Germany digital therapeutics market, by sales channel
7.3.2.7.France digital therapeutics market, by application
7.3.2.8.France digital therapeutics market, by product type
7.3.2.9.France digital therapeutics market, by sales channel
7.3.2.10.Italy digital therapeutics market, by application
7.3.2.11.Italy digital therapeutics market, by product type
7.3.2.12.Italy digital therapeutics market, by sales channel
7.3.2.13.Spain digital therapeutics market, by application
7.3.2.14.Spain digital therapeutics market, by product type
7.3.2.15.Spain digital therapeutics market, by sales channel
7.3.2.16.Rest of Europe digital therapeutics market, by application
7.3.2.17.Rest of Europe digital therapeutics market, by product type
7.3.2.18.Rest of Europe digital therapeutics market, by sales channel

7.3.3.Europe digital therapeutics market, by application
7.3.4.Europe digital therapeutics market, by product type
7.3.5.Europe digital therapeutics market, by sales channel

7.4.Asia-pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific digital therapeutics market, by country


7.4.2.1.Japan digital therapeutics market, by application
7.4.2.2.Japan digital therapeutics market, by product type
7.4.2.3.Japan digital therapeutics market, by sales channel
7.4.2.4.China digital therapeutics market, by application
7.4.2.5.China digital therapeutics market, by product type
7.4.2.6.China digital therapeutics market, by sales channel
7.4.2.7.Australia digital therapeutics market, by application
7.4.2.8.Australia digital therapeutics market, by product type
7.4.2.9.Australia digital therapeutics market, by sales channel
7.4.2.10.India digital therapeutics market, by application
7.4.2.11.India digital therapeutics market, by product type
7.4.2.12.India digital therapeutics market, by sales channel
7.4.2.13.South Korea digital therapeutics market, by application
7.4.2.14.South Korea digital therapeutics market, by product type
7.4.2.15.South Korea digital therapeutics market, by sales channel
7.4.2.16.Rest of Asia-Pacific digital therapeutics market, by application
7.4.2.17.Rest of Asia-Pacific digital therapeutics market, by product type
7.4.2.18.Rest of Asia-Pacific digital therapeutics market, by sales channel

7.4.3.Asia-Pacific digital therapeutics market, by application
7.4.4.Asia-Pacific digital therapeutics market, by product type
7.4.5.Asia-Pacific digital therapeutics market, by sales channel

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA digital therapeutics market, by country


7.5.2.1.Brazil digital therapeutics market, by application
7.5.2.2.Brazil digital therapeutics market, by product type
7.5.2.3.Brazil digital therapeutics market, by sales channel
7.5.2.4.Turkey digital therapeutics market, by application
7.5.2.5.Turkey digital therapeutics market, by product type
7.5.2.6.Turkey digital therapeutics market, by sales channel
7.5.2.7.Saudi Arabia digital therapeutics market, by application
7.5.2.8.Saudi Arabia digital therapeutics market, by product type
7.5.2.9.Saudi Arabia digital therapeutics market, by sales channel
7.5.2.10.South Africa digital therapeutics market, by application
7.5.2.11.South Africa digital therapeutics market, by product type
7.5.2.12.South Africa digital therapeutics market, by sales channel
7.5.2.13.Rest of LAMEA digital therapeutics market, by application
7.5.2.14.Rest of LAMEA digital therapeutics market, by product type
7.5.2.15.Rest of LAMEA digital therapeutics market, by sales channel

7.5.3.LAMEA digital therapeutics market, by application
7.5.4.LAMEA digital therapeutics market, by product type
7.5.5.LAMEA digital therapeutics market, by sales channel

CHAPTER 8:COMPANY PROFILES

8.1.2MORROW, INC.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Key strategic moves and developments

8.2.AKILI INTERACTIVE LABS, INC.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Product portfolio
8.2.4.Key strategic moves and developments

8.3.CLICK THERAPEUTICS, INC.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments

8.4.FITBIT, INC. (TWINE HEALTH, INC.)

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Product portfolio
8.4.4.Business performance
8.4.5.Key strategic moves and developments

8.5.HAPPIFY, INC.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Product portfolio
8.5.4.Key strategic moves and developments

8.6.KAIA HEALTH

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Product portfolio
8.6.4.Key strategic moves and developments

8.7.LIVONGO HEALTH, INC.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Product portfolio
8.7.4.Key strategic moves and developments

8.8.MEDTRONIC PLC.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.OMADA HEALTH, INC.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Key strategic moves and developments

8.10.PEAR THERAPEUTICS, INC.

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Product portfolio
8.10.4.Key strategic moves and developments

8.11.PROTEUS DIGITAL HEALTH, INC.

8.11.1.Company overview
8.11.2.Company snapshot
8.11.3.Operating business segments
8.11.4.Product portfolio
8.11.5.Key strategic moves and developments

8.12.RESMED, INC. (PROPELLER HEALTH)

8.12.1.Company overview
8.12.2.Company snapshot
8.12.3.Operating business segments
8.12.4.Product portfolio
8.12.5.Business performance
8.12.6.Key strategic moves and developments

8.13.VOLUNTIS, INC.

8.13.1.Company overview
8.13.2.Company snapshot
8.13.3.Operating business segments
8.13.4.Product portfolio
8.13.5.Business performance
8.13.6.Key strategic moves and developments

8.14.WELLDOC, INC.

8.14.1.Company overview
8.14.2.Company snapshot
8.14.3.Operating business segments
8.14.4.Product portfolio
8.14.5.Key strategic moves and developments

TABLE 01. GLOBAL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 02. DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 20172025 ($MILLION)

TABLE 03. DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 20172025 ($MILLION)

TABLE 04. DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 20172025 ($MILLION)

TABLE 05. DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY REGION, 20172025 ($MILLION)

TABLE 06. SMART PILLS FOR CAPSULE ENDOSCOPY, DRUG DELIVERY, AND PATIENT MONITORING AVAILABLE IN THE MARKET

TABLE 07. DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY REGION, 20172025 ($MILLION)

TABLE 08. DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY REGION, 20172025 ($MILLION)

TABLE 09. DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 20172025 ($MILLION)

TABLE 10. DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY REGION, 20172025 ($MILLION)

TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET, BY PRODUCT, 20172025 ($MILLION)

TABLE 12. DIGITAL THERAPEUTIC APPLICATIONS AND SOFTWARE PLATFORMS

TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY REGION, 20172025 ($MILLION)

TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY REGION, 20172025 ($MILLION)

TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)

TABLE 16. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY TYPE, 20172025 ($MILLION)

TABLE 17. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY REGION, 20172025 ($MILLION)

TABLE 18. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY TYPE, 20172025 ($MILLION)

TABLE 19. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY REGION, 20172025 ($MILLION)

TABLE 20. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE, BY REGION, 20172025 ($MILLION)

TABLE 21. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 22. U.S. DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 23. U.S. DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 24. U.S. DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 25. CANADA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 26. CANADA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 27. CANADA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 28. MEXICO DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 29. MEXICO DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 30. MEXICO DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 31. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 32. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 33. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 34. EUROPE DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 35. UK DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 36. UK DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 37. UK DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 38. GERMANY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 39. GERMANY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 40. GERMANY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 41. FRANCE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 42. FRANCE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 43. FRANCE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 44. ITALY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 45. ITALY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 46. ITALY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 47. SPAIN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 48. SPAIN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 49. SPAIN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 50. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 51. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 52. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 53. EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 54. EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 55. EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 56. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 57. JAPAN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 58. JAPAN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 59. JAPAN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 60. CHINA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 61. CHINA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 62. CHINA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 63. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 64. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 65. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 66. INDIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 67. INDIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 68. INDIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 69. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 70. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 71. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 72. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 73. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 74. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 75. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 76. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 77. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 78. LAMEA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 79. BRAZIL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 80. BRAZIL DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 81. BRAZIL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 82. TURKEY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 83. TURKEY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 84. TURKEY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 85. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 86. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 87. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 88. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 89. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 90. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 91. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 92. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 93. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 94. LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 95. LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 96. LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 97. PROTEUS: COMPANY SNAPSHOT

TABLE 98. PROTEUS: PRODUCT PORTFOLIO

TABLE 99. OMADA: COMPANY SNAPSHOT

TABLE 100. WELLDOC: COMPANY SNAPSHOT

TABLE 101. 2MORROW: COMPANY SNAPSHOT

TABLE 102. LIVONGO: COMPANY SNAPSHOT

TABLE 103. LIVONGO: PRODUCT PORTFOLIO

TABLE 104. PROPELLER: COMPANY SNAPSHOT

TABLE 105. TWINE: COMPANY SNAPSHOT

TABLE 106. CANARY: COMPANY SNAPSHOT

TABLE 107. CANARY: PRODUCT PORTFOLIO

TABLE 108. NOOM: COMPANY SNAPSHOT

TABLE 109. MEDTRONIC: COMPANY SNAPSHOT

TABLE 110. MEDTRONIC: OPERATING SEGMENTS

TABLE 111. MEDTRONIC: PRODUCT PORTFOLIO FIGURE 01. DIGITAL THERAPEUTICSS MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS IN DIGITAL THERAPEUTICSS MARKET, 2017

FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*

FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)

FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2014-2018*

FIGURE 06. TOP PLAYER POSITIONING, 2017

FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS

FIGURE 08. HIGH BARGAINING POWER OF BUYERS

FIGURE 09. LOW THREAT OF SUBSTITUTION

FIGURE 10. MODERATE THREAT OF NEW ENTRANT

FIGURE 11. MODERATE COMPETITIVE RIVALRY

FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY

FIGURE 13. DIGITAL THERAPEUTICS MARKET BY APPLICATION

FIGURE 14. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DIABETES , BY COUNTRY, 2017 & 2025, 2023 ($MILLION)

FIGURE 15. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 16. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 17. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 18. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 19. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 20. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 21. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 22. DIGITAL THERAPEUTICS MARKET, BY PRODUCT

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY COUNTRY, 2017 & 2024 (%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY COUNTRY, 2017 & 2024 (%)

FIGURE 25. DIGITAL THERAPEUTICS MARKET BY SALES CHANNEL

FIGURE 26. COMPARATIVE ANALYSIS OF BUSINESS-TO-BUSINESS MARKET, BY COUNTRY 2017-2025 ($MILLION)

FIGURE 27. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY EMPLOYER, 20172025 ($MILLION)

FIGURE 28. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY HEALTHCARE PROVIDERS, 20172025 ($MILLION)

FIGURE 29. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY OTHERS, 20172025 ($MILLION)

FIGURE 30. COMPARATIVE ANALYSIS OF BUSINESS-TO-CONSUMERS, BY COUNTRY 2017-2025 ($MILLION)

FIGURE 31. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY PATIENTS, 20172025 ($MILLION)

FIGURE 32. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY CAREGIVERS, 20172025 ($MILLION)

FIGURE 33. MEDTRONIC, 20152017 ($MILLION)

FIGURE 34. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 35. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$6168
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$10663
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Electronic (PDF)
$6929
This license allows maximum 5 users to access the PDF
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

Global Torasemide API Market Research Report 2022
Global Torasemide API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-37B11450
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Baloxavir Marboxil API Market Research Report 2022
Global Baloxavir Marboxil API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-39E11527
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2022
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-29D11405
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Chemiluminescence Immunodiagnostic Market Research Report 2022
Global Chemiluminescence Immunodiagnostic Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-18X11631
Fri Aug 12 00:00:00 UTC 2022

Add to Cart